Adam H. Dyer

4.2k total citations · 1 hit paper
48 papers, 1.3k citations indexed

About

Adam H. Dyer is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Physiology. According to data from OpenAlex, Adam H. Dyer has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 8 papers in Cognitive Neuroscience and 8 papers in Physiology. Recurrent topics in Adam H. Dyer's work include Dementia and Cognitive Impairment Research (19 papers), Blood Pressure and Hypertension Studies (5 papers) and Alzheimer's disease research and treatments (5 papers). Adam H. Dyer is often cited by papers focused on Dementia and Cognitive Impairment Research (19 papers), Blood Pressure and Hypertension Studies (5 papers) and Alzheimer's disease research and treatments (5 papers). Adam H. Dyer collaborates with scholars based in Ireland, United Kingdom and Italy. Adam H. Dyer's co-authors include Daniela Tropea, Cyrus Vahdatpour, Seán Kennelly, Albert Sanfeliu, Nollaig M. Bourke, Desmond O’Neill, Cliona O’Farrelly, Niall Conlon, Robert Briggs and Ciarán Bannan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neuroscience.

In The Last Decade

Adam H. Dyer

46 papers receiving 1.2k citations

Hit Papers

Persistent Poor Health af... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam H. Dyer Ireland 18 359 246 233 175 173 48 1.3k
R. Ross Reichard United States 19 935 2.6× 273 1.1× 263 1.1× 156 0.9× 107 0.6× 69 1.7k
Pedro Braga‐Neto Brazil 22 914 2.5× 211 0.9× 85 0.4× 475 2.7× 93 0.5× 133 1.8k
Piergiorgio Lochner Italy 28 977 2.7× 248 1.0× 42 0.2× 87 0.5× 102 0.6× 104 2.1k
Alan B. Frol United States 17 401 1.1× 258 1.0× 123 0.5× 96 0.5× 49 0.3× 24 1.4k
Ayush Batra United States 18 1.0k 2.9× 305 1.2× 401 1.7× 208 1.2× 306 1.8× 54 1.8k
Melanie Dani United Kingdom 16 616 1.7× 256 1.0× 187 0.8× 175 1.0× 164 0.9× 46 1.4k
Alexandre Paim Díaz Brazil 20 288 0.8× 324 1.3× 35 0.2× 284 1.6× 302 1.7× 80 1.6k
Aylin Y. Reid Canada 15 308 0.9× 468 1.9× 41 0.2× 154 0.9× 62 0.4× 27 1.4k
Hannah C. Glass United States 44 351 1.0× 1.4k 5.7× 230 1.0× 312 1.8× 45 0.3× 147 5.8k
Livia De Picker Belgium 20 193 0.5× 420 1.7× 104 0.4× 124 0.7× 270 1.6× 72 1.2k

Countries citing papers authored by Adam H. Dyer

Since Specialization
Citations

This map shows the geographic impact of Adam H. Dyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam H. Dyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam H. Dyer more than expected).

Fields of papers citing papers by Adam H. Dyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam H. Dyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam H. Dyer. The network helps show where Adam H. Dyer may publish in the future.

Co-authorship network of co-authors of Adam H. Dyer

This figure shows the co-authorship network connecting the top 25 collaborators of Adam H. Dyer. A scholar is included among the top collaborators of Adam H. Dyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam H. Dyer. Adam H. Dyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dyer, Adam H., Jean Dunne, Laura Morrison, et al.. (2025). Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 17(1). e70080–e70080. 4 indexed citations
2.
Hernández, Belinda, Adam H. Dyer, Ciarán Finucane, et al.. (2024). The Impact of Type 2 Diabetes on Peripheral and Cerebral Hemodynamic Responses to Active Stand. The Journals of Gerontology Series A. 79(5).
4.
6.
Brady, Gareth, William McCormack, Adam H. Dyer, et al.. (2023). Type 1 interferon auto-antibodies are elevated in patients with decompensated liver cirrhosis. Clinical & Experimental Immunology. 215(2). 177–189.
7.
Dyer, Adam H., et al.. (2023). An Update on Apathy in Alzheimer’s Disease. Geriatrics. 8(4). 75–75. 13 indexed citations
8.
Woudenberg, Tom, Jason Rosado, Adam H. Dyer, et al.. (2022). Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination. Viruses. 14(7). 1491–1491. 14 indexed citations
9.
Dyer, Adam H., Éamon Laird, Leane Hoey, et al.. (2022). Reduced kidney function is associated with poorer domain‐specific cognitive performance in community‐dwelling older adults. International Journal of Geriatric Psychiatry. 37(7). 8 indexed citations
10.
Dyer, Adam H., Éamon Laird, Leane Hoey, et al.. (2021). Long‐term anticholinergic, benzodiazepine and Z‐drug use in community‐dwelling older adults: What is the impact on cognitive and neuropsychological performance?. International Journal of Geriatric Psychiatry. 36(11). 1767–1777. 7 indexed citations
11.
Townsend, Liam, Adam H. Dyer, Kate O’Brien, et al.. (2021). Investigating the Relationship between Vitamin D and Persistent Symptoms Following SARS-CoV-2 Infection. Nutrients. 13(7). 2430–2430. 28 indexed citations
12.
Dyer, Adam H., Robert Briggs, Éamon Laird, et al.. (2021). Glycated haemoglobin (HbA1c), diabetes and neuropsychological performance in community‐dwelling older adults. Diabetic Medicine. 38(11). e14668–e14668. 3 indexed citations
13.
Townsend, Liam, Helen Fogarty, Adam H. Dyer, et al.. (2021). Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response. Journal of Thrombosis and Haemostasis. 19(4). 1064–1070. 120 indexed citations
14.
Dyer, Adam H., et al.. (2021). Long‐term antipsychotic use and cognitive decline in community‐dwelling older adults with mild–moderate Alzheimer disease: Data from NILVAD. International Journal of Geriatric Psychiatry. 36(11). 1708–1721. 4 indexed citations
15.
Kennelly, Seán, Adam H. Dyer, Ruth Elwood Martin, et al.. (2020). Asymptomatic carriage rates and case fatality of SARS-CoV-2 infection in residents and staff in Irish nursing homes. Age and Ageing. 50(1). 49–54. 29 indexed citations
16.
Dyer, Adam H., Louise McKenna, Nollaig M. Bourke, et al.. (2020). Cognitive performance in midlife type 2 diabetes: results from the ENBIND study. Diabetic Medicine. 38(6). e14412–e14412. 15 indexed citations
17.
Dyer, Adam H., et al.. (2020). Social networks in mild-to-moderate Alzheimer disease: longitudinal relationships with dementia severity, cognitive function, and adverse events. Aging & Mental Health. 25(10). 1923–1929. 29 indexed citations
18.
Dyer, Adam H., et al.. (2020). Antidepressant use and orthostatic hypotension in older adults living with mild‐to‐moderate Alzheimer disease. International Journal of Geriatric Psychiatry. 35(11). 1367–1375. 5 indexed citations
19.
Dyer, Adam H., et al.. (2019). Is Ongoing Anticholinergic Burden Associated With Greater Cognitive Decline and Dementia Severity in Mild to Moderate Alzheimer’s Disease?. The Journals of Gerontology Series A. 75(5). 987–994. 14 indexed citations
20.
Pini, Giorgio, Stefania Bigoni, Adam H. Dyer, et al.. (2016). Illness Severity, Social and Cognitive Ability, and EEG Analysis of Ten Patients with Rett Syndrome Treated with Mecasermin (Recombinant Human IGF-1). SHILAP Revista de lepidopterología. 2016. 1–9. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026